Member Info for Bazzaman

As Monday 25th is a bank holiday it is more likely to be Tuesday 26th which coincides with his 10 days.

End of September for half year 2020 should be more interesting IMHO.

End of May 2020 for year ending 31st Dec 2019.

The test as shown on their web page.

https://quotientbd.com/covid-19

Quotient Ltd although quoted on NASDAQ & have an office in Pennsylvania are headquartered in Switzerland. Franz waltz CEO since 2018 spend 23 years at Roche.
http://investors.quotientbd.com/corporate-governance/management

An extract from them 11/5;

Open Orphan has blown past our early May price target of 10p and we are now raising our conservative target for the end of next quarter to 20p.

The shares are now changing hands for 13p and in our opinion should be re-rated higher shortly.

The Anglo-Irish pharma group added that finnCap had been appointed its new join broker with immediate effect. This is another strong sign for Open Orphan.

The investment bank has raise large expansion funds for other Covid-19 testing and treatment candidates. That includes £14m for Synairgen (LSE:SNG) to fund a Phase II trail of its interferon beta-based Covid-19 treatment candidate and £7m for molecular diagnostic developer Genedrive (LSE: GDR), helping it to fund the development of two Covid-19 diagnostic tests

Not sure if this has been posted before but an interesting interview with Franz Walt on 5th May before tie-up with OO
https://www.quotientbd.com/news/quotient-ceo-franz-walt-talkradio-mike-graham

On TW he sold less than 50% of his holding at 10.55p, with hindsight a bit premature probably. Is he right about the need for a RNS given what CF has been saying about cost of test and volumes , I would say yes. CF indicated that would happen anyway around 25th/26th but I wouldn't be surprised if that broke sooner given the numbers involved. GLA

Due on Tuesday, I topped up yesterday at ridiculous low price. Nice IC update rivaldo. BOL

Plenty of buyers now, tight spread 7.00/7.10 GLA

Ticking up, 13.4/13.5 tight spread.

Details of the partnership with Quotient will surface in a RNS as soon as they are ready to open the clinic for the first tests. He said yesterday 10 days before they open, either Monday 25th or Tuesday 26th. Patience will be rewarded IMHO. GLA.

Greatland Gold set for its next rally leading up to next Newcrest Havieron update in the coming weeks IMHO. The buy on rumour sell on facts folk are out. The gold price is flying. My call is #GGP will now creep past all time high to 15.

My question on Wednesday's presentation and their response.

Q17: With your market cap of c£23m are you concerned that you are vulnerable to takeover?
Our rating is seriously depressed which is not unusually or surprising given whats going on in the world but people will start to go out again at some point, planes will fly again and oil prices ought to rise again. On this basis, now is an obvious time for consolidation in the sector and any deeply discounted company under these circumstances will be having the ruler put over them. There’s always somebody bigger than you so in short yes there is always the possibility that this can happen.

Collectively, the Board, family and friends hold c. 40% of total shareholding, and any takeover bid will be difficult as a result. Given the future trajectory, any takeover, at the very least will be in the interest of all shareholders.

GLA

BOL could be Bollinger but for me Best Of Luck.

Gunfish - no but predicting them is not easy, contract updates, antibodies testing, Imutex, Genomic - what's not to like. BOL

One a week every Monday will do me. GLA

Fairview, are you happy now that you know when the clinic is reopening?

IMHO the deal with Quotient is a partnership whereby both parties prosper.

https://www.investorschronicle.co.uk/comment/2020/05/14/hunting-down-undervalued-small-cap-buys/ Target price 40p. GLA

Looks like in the next 2 weeks there will be substantial news to push the SP northwards, clinic open for testing anti-bodies, new contracts (maybe). He is working on producing a new presentation which should be up on their web-site outlining how these things all pull together.
End of the Summer for the Genomic data bank being ready for subscription service.